Rosanna Santoro

Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3

Alessandra Mangia, Rosanna Santoro, Nicola Minerva et al. · New England Journal of Medicine · 2005 · 839 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response

Alessandra Mangia, Alexander Thompson, Rosanna Santoro et al. · Gastroenterology · 2010 · 316 citations · Full text

Life Sciences, Genetics, Immunology +13

TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

Carolina Boni, Andrea Vecchi, Marzia Rossi et al. · Gastroenterology · 2018 · 149 citations

Life Sciences, Immunology, Pharmacology +13

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Carolina Boni, Harry L.A. Janssen, Marzia Rossi et al. · Gastroenterology · 2019 · 140 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

Ewa Terczyńska‐Dyla, Stéphanie Bibert, François H.T. Duong et al. · Nature Communications · 2014 · 130 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17